DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story

starstarstarstarempty star (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

 

More Industry Headlines

Carestream introduces a more affordable DRX-Transportable System/Lite retrofit solution Equipped with a wireless tablet PC

MR shows promise for predicting neurological outcomes in cardiac arrest survivors May also help develop therapies

New machine learning tool identifies breast lesions likely to become cancerous May help reduce unnecessary surgical procedures

FDA gives nod to TransEnterix Senhance Surgical Robotic System Provides greater control while reducing abdominal surgery invasiveness

Bracco Imaging acquires SurgVision Enables development of a real-time fluorescence image-guided surgery platform

CT lung cancer screening combined with smoking cessation is worth expense $14,000 saved per quality-adjusted life-years gained: study

Phase I trial demonstrates safe use of radiotracer produced in minutes Manufactured using a Ga-68 generator and a cold kit vial

Esaote launches MyLab9 eXP ultrasound system Designed to enhance image clarity, workflow and performance

New research finds brain MR study groups don't reflect U.S. population demographics This must change for large, multicenter studies

Jonas Salk’s gift to the world Polio was a scourge, his education matched well with what was needed to find a cure

CyberKnife "valid option" for low-risk prostate cancer: study

by Brendon Nafziger , DOTmed News Associate Editor
A follow-up study using CyberKnife stereotactic body radiation for low-risk prostate cancer found most patients had disease-free survival after five years, with little toxicity, results that researchers say could help bolster support for the treatment.

"In our mind, it's no longer investigational or experimental therapy," study co-author Dr. Debra E. Freeman, a radiation oncologist with CyberKnife Centers of Tampa Bay in Florida, told DOTmed News. "It's a valid option in the treatment of low-risk prostate cancer."

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



CyberKnife is a robotic radiosurgery device made by Accuray Inc. of Sunnyvale, Calif., which can deliver "hypofractionated" treatments -- that is, high doses of radiation precisely sculpted to the tumor or target, and delivered in a smaller number of sessions. It was approved by the U.S. Food and Drug Administration to treat tumors anywhere in the body around nine years ago.

For the study, the patients received between 35 and 36.25 Gy in five fractions.

Freeman said slower growing, "indolent" prostate cancers are thought to respond better to hypofractionated treatment, as opposed to radiotherapy treatments where smaller doses are spread out over a longer time. "They are not exquisitely sensitive to low doses of radiation, and are more sensitive and respond more to higher doses of radiation," she said.

More aggressive, faster spreading cancers tend to be treated with lower, more frequent doses, she said.

In the study, published online this week in Radiation Oncology, researchers examined results from a pooled group of 41 patients from Stanford, Calif. and Naples, Fla., who received treatment between 2003 and 2005. The main endpoint was biochemical disease-free survival after five years, a standard measure that looks at whether prostate-specific antigen levels remain low and stable following treatment, suggesting disease is absent.

For the patients, at a median five years after therapy the biochemical disease-free survival was around 93 percent, results comparable with surgery and other forms of radiation therapy, Freeman said.

Toxic side effects from zapping the prostate were also rare, with no rectal bleeding or ulcerations, and no significant damage to the bladder, Freeman said.

"With any kind of radiation, there's a risk of some damage," she said. "You can't really get to the prostate with radiation without brushing by the bladder and the rectum on the way there. They can be injured in surgery, as well."

However, one patient did have a urologic problem, but Freeman said it was unclear if it was caused by the radiation treatment or an earlier procedure used to dilate the urethra because of difficulties passing urine.
  Pages: 1 - 2 >>

Related:


Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED